Retrospective analysis of drug utilization, health care resource use, and costs associated with IFN therapy for adjuvant treatment of malignant melanoma by Zhang Y, Le TK, Shaw JW, Kotapati S

Get full text

Incidence and impact of pain conditions and comorbid illnesses by Davis JA, Robinson RL, Le TK, Xie J

Get full text

Health care costs in US patients with and without a diagnosis of osteoarthritis by Le TK, Montejano LB, Cao Z, Zhao Y, Ang D

Get full text

Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study by Dalle, S, Mortier, L, Corrie, P, Lotem, M, Board, R, Arance, AM, Meiss, F, Terheyden, P, Gutzmer, R, Buysse, B, Oh, K, Brokaw, J, Le, TK, Mathias, SD, Scotto, J, Lord-Bessen, J, Moshyk, A, Kotapati, S, Wilkinson, J